Copyright
©The Author(s) 2020.
World J Gastrointest Pathophysiol. Apr 12, 2020; 11(2): 20-31
Published online Apr 12, 2020. doi: 10.4291/wjgp.v11.i2.20
Published online Apr 12, 2020. doi: 10.4291/wjgp.v11.i2.20
Table 1 Definitions of Pancreatic Exocrine Insufficiency after pancreaticoduodenectomy
| Ref. | Definition of pancreatic exocrine insufficiency |
| Sabater et al[8] | Condition wherein the amount of pancreatic secretions is not enough to maintain normal digestion |
| Ghaneh et al[28] | Need for new pharmacological intervention for exocrine insufficiency i.e. PERT |
| Sikkens et al[11] | Faecal elastase-1 < 0.200 mg/g of faeces |
| Halloran et al[29] | Coefficient of fat absorption < 93% |
| Domínguez-Muñoz et al[30] | 13C-mixed triglyceride test (Percent cumulative dose of < 5% of 13CO2 at 7 h) |
| Yamaguchi et al[31] | BT-PABA excretion rate of < 70% |
| Kato et al[32] | Abnormal secretin stimulation test |
| Perez et al[33] | 72 h faecal fat estimation |
| Fang et al[34] | Faecal chymotrypsin estimation |
Table 2 Biochemical tests in the assessment of pancreatic exocrine insufficiency
| Nutritional assessment | Evaluation of pancreatic function | |
| Exocrine markers | Markers of malabsorption | |
| Fat soluble vitamins | Faecal elastase-1 | 72 h faecal fat estimation |
| Bone profile | Faecal chymotrypsin | BT-PABA absorption |
| Iron and Ferritin studies | Secretin stimulation test | 13C labelled trioctanoin breath test |
| Micronutrient status | ||
| Glycaemic status | ||
Table 3 Incidence of pancreatic exocrine insufficiency before and after pancreaticoduodenectomy
| Ref. | Pre-operative incidence of PEI | Post-operative incidence of PEI | Diagnostic test |
| Kato et al[32] | 93% | 80% | Secretin stimulation |
| Halloran et al[29] | - | 55% | Coefficient of fat absorption |
| Yuasa et al[42] | - | 64% | 13C- mixed triglyceride test |
| Nakamura et al[9] | - | 62.3% | |
| Hirono et al[43] | - | 51% | |
| Benini et al[41] | - | 87.5% | 72 h faecal fat estimation |
| Lemaire et al[44] | - | 94% | |
| Sato et al[45] | 46% | 33% | BT-PABA excretion |
| Fujino et al[46] | - | 75% | |
| Matsumoto et al[47] | 68% | 50% | Faecal elastase-1 |
| Van der Gaag et al[48] | - | 59% | |
| Tran et al[49] | - | 91% | |
| Pessaux et al[50] | - | 95% | |
| Jang et al[51] | - | 100% | |
| Falconi et al[52] | - | 24% | Faecal chymotrypsin |
| Fang et al[34] | - | 33% | |
| Bock et al[53] | - | 52.8% | Steatorrhoea |
| Rault et al[54] | - | 42% | |
| Van Berge Henegouwen et al[55] | - | 64.5% |
Table 4 Incidence of pancreatic exocrine insufficiency after pancreaticoduodenectomy–evidence on the role of the type of pancreatic reconstruction
| Ref. | Diagnostic test | Incidence of PEI–Pancreaticogastrostomy | Incidence of PEI–Pancreaticojejunostomy |
| Nakamura et al[9] | 13C Triglyceride breath test | 62.3% | - |
| Lemaire et al[44] | Faecal Fat excretion and faecal elastase-1 | 100% | - |
| Jang et al[51] | Faecal elastase-1 | 100% (severe) | 75% (severe); 20% (mild) |
| Roeyen et al[63] | Need for PERT +/- any abnormal pancreatic function test | 75% | 45.7% (P < 0.001) |
| Rault et al[54] | Steatorrhoea | 70% | 21.7% (P < 0.025) |
- Citation: Pathanki AM, Attard JA, Bradley E, Powell-Brett S, Dasari BVM, Isaac JR, Roberts KJ, Chatzizacharias NA. Pancreatic exocrine insufficiency after pancreaticoduodenectomy: Current evidence and management. World J Gastrointest Pathophysiol 2020; 11(2): 20-31
- URL: https://www.wjgnet.com/2150-5330/full/v11/i2/20.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v11.i2.20
